These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8893989)

  • 21. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
    Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestation.
    Flanagan M; Johnson SJ
    Aust Vet J; 1995 Dec; 72(12):455-7. PubMed ID: 8825310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence after vaccination of cattle and sheep against Bluetongue Virus (BTV) serotype 8 in Sweden.
    Hultén C; Frössling J; Chenais E; Sternberg Lewerin S
    Transbound Emerg Dis; 2013 Oct; 60(5):438-47. PubMed ID: 22889362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
    Stewart M; Dubois E; Sailleau C; Bréard E; Viarouge C; Desprat A; Thiéry R; Zientara S; Roy P
    Vaccine; 2013 Jan; 31(3):553-8. PubMed ID: 23159460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bluetongue serotype 2 and 9 modified live vaccine viruses as causative agents of abortion in livestock: a retrospective analysis in Italy.
    Savini G; Lorusso A; Paladini C; Migliaccio P; Di Gennaro A; Di Provvido A; Scacchia M; Monaco F
    Transbound Emerg Dis; 2014 Feb; 61(1):69-74. PubMed ID: 22937914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep.
    Pérez de Diego AC; Athmaram TN; Stewart M; Rodríguez-Sánchez B; Sánchez-Vizcaíno JM; Noad R; Roy P
    PLoS One; 2011; 6(10):e26666. PubMed ID: 22046324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.
    Es-Sadeqy Y; Bamouh Z; Ennahli A; Safini N; El Mejdoub S; Omari Tadlaoui K; Gavrilov B; El Harrak M
    Vet Microbiol; 2021 May; 256():109046. PubMed ID: 33780805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera.
    Bréard E; Gorlier A; Viarouge C; Donnet F; Sailleau C; Schulz C; Hoffmann B; Comtet L; Beer M; Zientara S; Vitour D
    Transbound Emerg Dis; 2019 Jan; 66(1):537-545. PubMed ID: 30394662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
    Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
    Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of recombinant bluetongue virus antigens, using dot immunobinding assay with serum from sheep and cattle.
    Naresh A; Roy P; Prasad G
    Am J Vet Res; 1996 Nov; 57(11):1556-8. PubMed ID: 8915428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.
    Feenstra F; van Rijn PA
    Crit Rev Microbiol; 2017 Mar; 43(2):142-155. PubMed ID: 27800699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine.
    Zhugunissov K; Yershebulov Z; Barakbayev K; Bulatov Y; Taranov D; Amanova Z; Abduraimov Y
    Vet Res Commun; 2015 Dec; 39(4):203-10. PubMed ID: 26280208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Grimm L; Meilwes J; Punsmann T; Blaha I; Salditt A; Rohn K; Bastian M; Ganter M
    Vaccine; 2019 Sep; 37(39):5844-5853. PubMed ID: 31431410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically engineered multi-component virus-like particles as veterinary vaccines.
    Pearson LD; Roy P
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.